Zurich Cantonal Bank’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $647K | Buy |
155,498
+92,068
| +145% | +$350K | ﹤0.01% | 1801 |
|
|
2026
Q1 | $223K | Buy |
63,430
+13,516
| +27% | +$43.2K | ﹤0.01% | 2213 |
|
|
2025
Q4 | $136K | Buy |
49,914
+15,992
| +47% | +$37K | ﹤0.01% | 2334 |
|
|
2025
Q3 | $73.6K | Sell |
33,922
-21,336
| -39% | -$50.4K | ﹤0.01% | 2417 |
|
|
2025
Q2 | $95K | Sell |
55,258
-44
| -0.1% | -$109 | ﹤0.01% | 2390 |
|
|
2025
Q1 | $184K | Sell |
55,302
-3,469
| -6% | -$17.9K | ﹤0.01% | 2143 |
|
|
2024
Q4 | $435K | Sell |
58,771
-401
| -0.7% | -$3.72K | ﹤0.01% | 1710 |
|
|
2024
Q3 | $556K | Buy |
59,172
+152
| +0.3% | +$1.44K | ﹤0.01% | 1496 |
|
|
2024
Q2 | $473K | Buy |
59,020
+267
| +0.5% | +$2.86K | ﹤0.01% | 1520 |
|
|
2024
Q1 | $871K | Buy |
58,753
+14,608
| +33% | +$170K | ﹤0.01% | 1134 |
|
|
2023
Q4 | $359K | Buy |
44,145
+5,155
| +13% | +$27K | ﹤0.01% | 1721 |
|
|
2023
Q3 | $177K | Buy |
38,990
+11,830
| +44% | +$77.2K | ﹤0.01% | 2042 |
|
|
2023
Q2 | $191K | Buy |
27,160
+12,399
| +84% | +$88.7K | ﹤0.01% | 1953 |
|
|
2023
Q1 | $90.2K | Hold |
14,761
| – | – | ﹤0.01% | 2340 |
|
|
2022
Q4 | $94.3K | Hold |
14,761
| – | – | ﹤0.01% | 2312 |
|
|
2022
Q3 | $141K | Hold |
14,761
| – | – | ﹤0.01% | 1972 |
|
|
2022
Q2 | $163K | Sell |
14,761
-3,486
| -19% | -$45.7K | ﹤0.01% | 1918 |
|
|
2022
Q1 | $304K | Sell |
18,247
-1,161
| -6% | -$18K | ﹤0.01% | 1645 |
|
|
2021
Q4 | $370K | Buy |
19,408
+6,217
| +47% | +$137K | ﹤0.01% | 1669 |
|
|
2021
Q3 | $325K | Sell |
13,191
-6
| -0% | -$141 | ﹤0.01% | 1579 |
|
|
2021
Q2 | $343K | Buy |
13,197
+61
| +0.5% | +$1.59K | ﹤0.01% | 1462 |
|
|
2021
Q1 | $416K | Sell |
13,136
-747
| -5% | -$31K | ﹤0.01% | 1349 |
|
|
2020
Q4 | $644K | Buy |
13,883
+1,924
| +16% | +$76.4K | ﹤0.01% | 1141 |
|
|
2020
Q3 | $394K | Buy |
11,959
+1,002
| +9% | +$30.7K | ﹤0.01% | 1202 |
|
|
2020
Q2 | $301K | Buy |
10,957
+1,672
| +18% | +$55K | ﹤0.01% | 1276 |
|
|
2020
Q1 | $278K | Buy |
9,285
+1,332
| +17% | +$35.3K | ﹤0.01% | 1069 |
|
|
2019
Q4 | $220K | Sell |
7,953
-1,360
| -15% | -$30.9K | ﹤0.01% | 1283 |
|
|
2019
Q3 | $169K | Hold |
9,313
| – | – | ﹤0.01% | 1324 |
|
|
2019
Q2 | $228K | Sell |
9,313
-3,405
| -27% | -$51.3K | ﹤0.01% | 1174 |
|
|
2019
Q1 | $121K | Hold |
12,718
| – | – | ﹤0.01% | 1460 |
|
|
2018
Q4 | $113K | Sell |
12,718
-1,200
| -9% | -$11.6K | ﹤0.01% | 1537 |
|
|
2018
Q3 | $157K | Hold |
13,918
| – | – | ﹤0.01% | 1450 |
|
|
2018
Q2 | $178K | Buy |
13,918
+5,318
| +62% | +$77.7K | ﹤0.01% | 1307 |
|
|
2018
Q1 | $145K | Buy |
+8,600
| New | +$130K | ﹤0.01% | 1389 |
|
Other funds holding IOVA
MFM
PAI
Zurich Cantonal Bank's IOVA Position: Q2 2026 in Review
Zurich Cantonal Bank increased its Iovance Biotherapeutics (IOVA) stake by 145% in Q2 2026, buying an estimated $350K and bringing the position to 155,498 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #1801.
Zurich Cantonal Bank first reported a position in IOVA in Q1 2018 and has held it in 34 quarters since. The position peaked at $871K in Q1 2024. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.
- Zurich Cantonal Bank held 155,498 shares of Iovance Biotherapeutics worth $647K as of Q2 2026.
- Zurich Cantonal Bank bought 92,068 Iovance Biotherapeutics shares in Q2 2026, an estimated $350K.
- Iovance Biotherapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1801 holding.
- Zurich Cantonal Bank first reported a position in Iovance Biotherapeutics in Q1 2018 and has held it in 34 quarters since.
- Zurich Cantonal Bank's Iovance Biotherapeutics position peaked at $871K in Q1 2024.
- 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.